Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
did Blum extol a McKinsey white paper X) $cytk https://t.co/sqeLo9jNgC
The CEO of Cytokinetics says the company is not for sale. That doesn't mean it would turn away potential suitors. https://t.co/JrRYYk9zUo
$CYTK Cytokinetics CEO it is not looking to be acquired, according to Stat News, but that doesn’t mean the company would turn away potential suitor
Cytokinetics, a biopharmaceutical company, is not seeking to be acquired, according to CEO Robert Blum. He stated that while the company is not for sale, it would not reject potential suitors. Cytokinetics is preparing to launch a new heart drug, which may attract interest from other firms. Blum's comments were reported in an interview with Stat News during the JPMorgan Healthcare Conference.
